Supreme Court Rejects J&J's (JNJ) Request to Reinstate Ruling Against Abbott (ABT) -Bloomberg
Up)
The US Supreme Court rejected Johnson & Johnson's (NYSE: JNJ) request to reinstate a $1.67 billion win against Abbott Labs (NYSE: ABT) related to arthritis treatments.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- DISH Network (DISH) Sued by Networks for 'Commercial Skipping' Feature
- Anglo American (AAUKY) will suspend its legal proceedings with Codelco in Chile
- Heads of Apple (AAPL), Samsung to Meet in Ongoing Patent Dispute
Create E-mail Alert Related Categories
Corporate News, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
